- Open Access
Silver nanoparticle protein corona and toxicity: a mini-review
Journal of Nanobiotechnology volume 13, Article number: 55 (2015)
Silver nanoparticles are one of the most important materials in the nanotechnology industry. Additionally, the protein corona is emerging as a key entity at the nanobiointerface; thus, a comprehensive understanding of the interactions between proteins and silver nanoparticles is imperative. Therefore, literature reporting studies involving both single molecule protein coronas (i.e., bovine and human serum albumin, tubulin, ubiquitin and hyaluronic-binding protein) and complex protein coronas (i.e., fetal bovine serum and yeast extract proteins) were selected to demonstrate the effects of protein coronas on silver nanoparticle cytotoxicity and antimicrobial activity. There is evidence that distinct and differential protein components may yield a “protein corona signature” that is related to the size and/or surface curvature of the silver nanoparticles. Therefore, the formation of silver nanoparticle protein coronas together with the biological response to these coronas (i.e., oxidative stress, inflammation and cytotoxicity) as well as other cellular biophysicochemical mechanisms (i.e., endocytosis, biotransformation and biodistribution) will be important for nanomedicine and nanotoxicology. Researchers may benefit from the information contained herein to improve biotechnological applications of silver nanoparticles and to address related safety concerns. In summary, the main aim of this mini-review is to highlight the relationship between the formation of silver nanoparticle protein coronas and toxicity.
Recently, silver nanoparticles have received a great deal of attention because of their distinctive physicochemical and biological properties. This interest originated with the use of silver nanoparticles in many different products because of their exceptionally small size and their potential antibacterial effect [1–3]. Currently, silver nanoparticles are primarily used for catalysis, transport, sensing and many other biological and medical applications [4, 5]. However, these applications have increased the possibility of living organisms being directly or indirectly exposed to silver nanoparticles, which could induce numerous deleterious effects on human health and the environment. The adverse effects (primary or secondary) of silver nanoparticles on organs can extend into the cardiovascular or central nervous system, thereby causing neurotoxicity or immunotoxicity [6, 7].
Important aspects of interactions between silver nanoparticle and cellular systems
The cytotoxicity and genotoxicity of silver nanoparticles depends on many factors (e.g., concentration, dispersion, size and surface functionalization) [8–11]. For example, reports have indicated that the size of silver nanoparticles is an important factor for cytotoxicity and genotoxicity, probably acting through apoptosis and necrosis mechanisms [12, 13]. Exposure of the human body to silver nanoparticles can occur through different routes (e.g., inhalation, ingestion, injection or physical contact with cuts or wounds); caution is necessary because some in vitro data suggest that even low concentrations of silver nanoparticles can be toxic in some cases [14–17]. Asharani et al.  showed by transmission electron microscopy (TEM) that silver nanoparticles can penetrate into cellular compartments such as endosomes, lysosomes and mitochondria (Fig. 1).
Many types of cells that interact with silver nanoparticles have been cultured and studied, including red blood cells, BRL3A rat liver cells, PC-12 neuroendocrine cells, GSCs germ line stem cells, RBE4 rat brain endothelial cells, MCF-7 human breast adenocarcinoma cells, HepG2 human liver cells, BEAS-2B bronchial epithelial cells, A4549 lung alveolar epithelial cells, and hMSC human mesenchymal stem cells (Fig. 2) [9, 18–30]. Thus far, data collected in vitro and in vivo indicate that the production of reactive oxygen species (ROS) plays an important role in the toxic effects of silver nanoparticles [31, 32] and is responsible for many changes (e.g., molecular and biochemical) related to genotoxicity in cultured cells (e.g., DNA breakage) . It is also stated in the literature that the dissolution of silver nanoparticles may have a key role in their toxicity [34, 35]. Moreover, many studies have suggested that the antimicrobial activity of silver nanoparticles on different types of pathogens depends on oxidative stress [36–39].
Knowledge of the chronic toxic effects that result from low-level exposure to silver nanoparticles is limited. A study of 10 nm silver, iron and gold nanoparticles demonstrated that all particles impeded epidermal growth factor (EGF)-dependent signal transduction, but by different mechanisms, as shown in Fig. 3. Silver nanoparticles produced a high ROS level and diminished serine/threonine protein kinase (Akt) and small guanosine triphosphate-binding protein/extracellular signal-regulated kinase (Erk) signaling. Silver nanoparticles significantly diminished the phosphorylation of Akt and Erk and inhibited Akt activity. Comfort et al.  stated that pretreatment with these metallic nanoparticles drastically interfered with the cellular response to EGF. Moreover, they reported that the major challenge is to be able to correlate the data obtained using an in vitro model and extrapolate the results to an in vivo system.
In an industrial environment, the most relevant occupational health risk from exposure to silver nanoparticles is inhalational; therefore, an important study was carried out with the A549 cell line, which is widely used as an in vitro model of pulmonary epithelial cells for nanotoxicity studies . The authors found that the toxicity of silver nanoparticles to these cells were mediated via ROS-dependent and also ROS-independent pathways .
When investigating the biological activities of silver nanoparticles, it is important to recognize that the nanoparticles will always interact with a protein medium, such as cell culture medium or a bacterial culture, prior to their biological actions. Therefore, the presence of a protein corona could make a vast difference to their biological activity. Consequently, it is important to review these topics and how they relate specifically to the interactions of silver nanoparticles with biological systems because this nanomaterial is exceedingly important in the market [6, 41].
General aspects of protein corona
The corona formation process depends on competition between proteins to be adsorbed onto the surface of nanoparticles. Miclaus et al.  suggested that the nanoparticle-protein interaction is dynamic, with exchanges between surface-bound and bulk proteins occurring on different time scales. Proteins with higher affinity for the surface exchange slowly, forming the hard corona, the innermost layer composed of tightly bound proteins (over longer periods of hours). Other proteins with low affinity are very quickly replaced, forming the soft corona, the outer layer composed of loosely bound proteins with lower affinity for the nanoparticle surface (over short time scales of seconds or minutes) (Fig. 4).
To better understand the interactions between nanoparticles and biological fluids, many studies have been performed in vitro and/or in vivo on tissues, on cells  and especially on proteins [44, 45]. All current data indicate that it is the proteins contained in the corona and not the nanoparticles themselves that interact with the cells [46, 47]. Therefore, the nanoparticle-corona complex is a new entity that represents “what the cell sees”, with the corona being the interface between the nanoparticle and the cellular system . Thus, under physiological conditions, the protein corona that forms on the surfaces of nanoparticles determines their biological identities [48–54]. It has been suggested that this protein corona is more significant in determining the biological response (i.e., immunogenicity) than the bare material properties of the particle itself .
The parameters that affect corona composition include particle size , particle shape  and particle surface  properties as well as biological fluid properties and composition . The formation of both soft and hard coronas is an equilibrium process in which the protein composition is directed by the initial concentration of each protein in the medium as well as its off rate (kback) . Corona formation and composition have important implications for both toxicity  and internalization .
Many studies have been performed on the long-lived, hard corona because it can be separated from the incubation medium through subsequent centrifugation and washing steps. However, it is important to note that this corona represents the proteins with longer residence times than the period of the washing steps in the separation process . Recently, Del Pino et al.  determined that each washing step causes a decrease in the bulk biomolecule concentration, which shifts the equilibrium of bound and unbound proteins and specifically removes the faster exchanging fraction .
These aspects are all related, in general, to different types of nanoparticles. Therefore, the overview herein will discuss a more specific topic, silver nanoparticles, and what has been published in this important area once silver is the most widely used nanostructured material with many potential effects in biological systems and even on environmental behavior [2, 4, 6, 60–65].
Specific aspects of silver nanoparticle protein coronas
Bovine serum albumin (BSA)
One of the first papers on protein coronas  used the structure of the bovine serum albumin (BSA) molecule because BSA is an adequate model system for the study of nanoparticle/protein interactions. In this study, two chemically synthesized silver nanoparticles with either a 20 nm diameter (3 × 1014 nm2 mL−1 surface area per mL) or a 40 nm diameter (3 × 1015 nm2 mL−1) capped with citrate and 70 nm silver nanoparticles capped with polyvinylpyrrolidone (PVP) were incubated with BSA. The α-helix content of the protein was analyzed using circular dichroism spectroscopy, which was based on different spectral intensities at 208 and 220 nm. BSA primarily contains α-helices as its secondary structural elements, and the loss of the structure of this protein shows the degree of disruption of interaction between BSA and the nanoparticles. The BSA signal decreased with an increase in the surface area of citrate-coated silver nanoparticle present in the mixture. The authors showed that the nanoparticle surface area required to remove free protein from the bulk solution corresponded well to the calculated amount of protein that could be adsorbed in a monolayer on the surface of the nanoparticles. Compared to citrate-stabilized silver nanoparticles, the interaction of BSA with PVP-stabilized silver nanoparticles revealed a different fate. Although the signal behavior showed similar aspects to the spectra run for citrate-coated silver nanoparticles, a completely different behavior was observed as the surface area of the nanoparticles was increased. The band at 208 nm decreased significantly compared to the second relative minimum at approximately 220 nm, which was completely different from citrate-silver nanoparticles and probably means that the mechanistic interpretation is more complex than in the case of citrate.
Treuel et al.  demonstrated that the behavior of proteins (such as BSA) towards nanoparticles could be strongly affected by the presence of polymer coatings, as previously discussed. Surface-enhanced Raman spectroscopy was used for further elucidation of protein binding to silver surfaces. The first interpretation of the differences in binding affinities for the citrate silver nanoparticles and the PVP silver nanoparticles was that the strong interactions between sulfur-containing groups in the protein and the metal surface was prevented when a polymer coating was present. The authors suggested that nanotoxicology might benefit from this information, which could be used to improve nanomedicinal applications. By using a wide range of polymer surface coatings, the biological transport and medical action of nanoparticles could be optimized. In the case of multiple-protein coronas, simulating real in vivo situations, the competition between the proteins present the medium is very expressive, thus the nanoparticle surface properties become even more relevant.
Similar results were published with different methodologies regarding albumin-silver nanoparticle interactions [67, 68]. Podila et al.  investigated the physiological and chemical interactions of a simple protein corona by studying the combination of a specific protein, such as BSA, with PVP- and citrate- stabilized silver nanoparticles. TEM images (Fig. 5a) confirmed that the uncoated silver nanoparticles produced via laser ablation (La-silver nanoparticles) were spherical with an unimodal diameter distribution (24 nm). The average diameter of citrate- and PVP-coated silver nanoparticles was approximately 20 nm. In the investigation of protein binding, an adequate amount of BSA (0–15 nM) was added to the silver nanoparticle suspension (10 µM) and thoroughly mixed via stirring to achieve good dispersion. Then, the suspensions were incubated at 37 °C for 1 h.
It can be observed in Fig. 5c–e that the La-silver nanoparticles exhibited more protein coating than the citrate- or PVP-coated silver nanoparticles. Moreover, the citrate- and PVP-coated silver nanoparticles aggregated upon exposure to proteins, indicating that their electrostatic stabilization groups were displaced from their surfaces.
In agreement with the TEM results (Fig. 5a), the dynamic light scattering results indicated that the Laser ablation (La)-silver nanoparticles supported the highest saturation amount of BSA compared to the citrate-and PVP-coated silver nanoparticles (Fig. 5b).
The ratio of the areas under the β-sheets to α-helices (I1630/I1650) by FTIR provided a quantitative measure for the net change in protein entropy. Native BSA had a ratio of <1, indicating an ordered form (higher α-helices). After the interaction of BSA with the nanoparticles, the ratios were greater than 1 (citrate-silver nanoparticles ~1.5, PVP-silver nanoparticles ~2.5 and La-silver nanoparticles ~9.5), indicating that all nanoparticle types induced an increase in the protein conformational entropy, or a decrease in α-helix content. Additionally, the change in conformational entropy was highest for the uncoated La- silver nanoparticles, consistent with previously observed protein adsorption on bulk surfaces. Finally, the authors found that uncoated and surfactant-free silver nanoparticles prepared using a physical process produced maximal BSA coatings owing to their increased changes in entropy. However, BSA exhibited a relatively lower affinity for electrostatically stabilized nanoparticles because it exerted constrained entropy changes.
This finding was similar that of Shannahan et al. , who found that 20 nm silver nanoparticles bound more strongly to hydrophobic proteins than did 110 nm silver nanoparticles. These authors suggested that the complexity and abundance of the protein corona constituents, in general, were related to the free energy in protein folding-unfolding induced by different surface components for silver nanoparticles of the same size. However, the differences in protein corona formation for 20 and 110 nm silver nanoparticles were most likely due to their surface curvature and the energy involved in protein adsorption and agglomeration. In other words, this report demonstrated the importance of electrostatic and hydrophobic interactions in protein corona formation, showing the broad biological and toxicological implications of these interactions. It is possible to conclude that the surface stabilization by different capped materials, a different BSA interaction occurred. The comparison of bare nanoparticles (laser ablation) versus citrate- or PVP-coated nanoparticles showed coated silver nanoparticles aggregated upon exposure to BSA, indicating that their electrostatic stabilization groups were offset from their surfaces. Then, BSA exhibited a relatively lower affinity for electrostatically stabilized nanoparticles because it exerted constrained entropy changes, thus, demonstrating the importance of electrostatic and hydrophobic interactions in protein corona formation from BSA.
Fetal calf and bovine serum
To understand PVP-stabilized silver nanoparticles, several protein moieties were studied. PVP-stabilized silver nanoparticles agglomerated and precipitated very fast in protein-free RPMI cell culture medium, which contains serum proteins [71, 72]. BSA partially prevented this agglomeration, but fetal calf serum (FCS) prevented the agglomeration entirely. The interaction of these two capped silver nanoparticles with FCS showed slight toxic effects against human mesenchymal stem cells. The toxicity of the silver nanoparticles is probably due to the release of silver ions and the BSA and FCS probably bind to these ions, thus avoiding their toxicity, although other factors can be acting simultaneously. It is also known that BSA and silver nanoparticles form complexes by van der Waals and electrostatic forces, and these metal ion–albumin complexes are easily internalized by cells . It is worth to notice that the formation of the corona around the silver nanoparticles may also affect their dissolution rates, likely affecting their overall toxicity. Therefore, the true nature of the protective effect of proteins needs further study, and silver nanoparticles must be used with care because their agglomeration behavior and the presence of proteins play important functional roles [71, 72].
To study the bond strength between nanoparticles and proteins and the progress of the equilibrium, Casals et al.  incubated citrate-silver nanoparticles (20 nm) in complete cell culture medium (cCCM), which consisted of Dulbecco’s modified Eagle’s medium [DMEM-10 % fetal bovine serum (FBS)] at a 10 % (v/v) dilution at 37 °C. These electrostatically stabilized silver nanoparticles were unstable when dispersed in solvents with a high ionic strength (e.g., DMEM) but stable when dispersed in the same solvents (e.g., DMEM) with 10 % FBS. Then, the adsorption/conjugation of proteins on the silver nanoparticle surfaces initiated as soon as the nanoparticles were dispersed in cCCM, which caused steric repulsion to occur more quickly than aggregation. In fact, the silver nanoparticle diameters were increased by up to twice the initial diameter. A simple purification process (centrifugation and resuspension in water) was carried out to distinguish the adsorbed protein from the free protein in solution. Part of the initial surface charge of the silver nanoparticles incubated with cCCM was recovered, indicating that only certain proteins remained attached to their surfaces and reached a stable/irreversible value. All data were indicative that the proteins had undergone a stabilization process, making them strong enough to maintain their final form as a hard protein corona over a long period of time in protein-free solutions. The authors suggested two steps in this process: (1) conjugation of a transient protein corona that forms immediately when nanoparticles contact the cCCM, which evolves a stable protein corona that remains bound to the nanoparticle surface even when the conjugates are taken out of cCCM and (2) redispersion in pure water (Scheme 1) .
Miclaus et al.  studied the interaction of silver nanocubes (synthesized by polyol synthesis and stabilized by PVP) with FBS, confirming the occurrence of a dynamic equilibrium process in which soft and hard coronas presented different exchange rates for this structure as well (Fig. 6).
Ashkarran et al.  studied soft and hard corona effects, investigating the interactions of four different silver nanoparticle structures (cube, sphere, wire and triangle) with FBS in situ. SDS-PAGE analysis was conducted to demonstrate the interaction of the nanoparticles with the proteins in this fluid. The authors found that the protein coronas had different concentrations and compositions depending on the nanoparticle structure, indicating that protein-nanoparticle interactions are morphology-dependent (Fig. 7). Its is worth to mention that not only the curvature effects differ from one nanoparticle shape to another, but also the coordination of the atoms on the available surfaces, leading to different surface energies for each different morphology, which might play a role in the protein binding. A future full understanding of the morphology role on nanoparticle-protein interactions and a very detailed characterization of the corona are essential to the achievement of the desired effects of the nanoparticles in vivo, opening room to future studies that might link the right morphology according to the required effect.
Shannahan et al.  characterized citrate-silver nanoparticles (24.4 nm, −46.6 mV zeta potential) and PVP-silver nanoparticles (26.6 nm, −35.9 mV zeta potential) in water or DMEM cell culture medium. A slight effect was observed when silver nanoparticles were suspended in DMEM without serum. From the results, it was clear that citrate-stabilized silver nanoparticles in water exhibited more negative zeta potentials than did PVP-stabilized nanoparticles of a similar diameter. Analyses of the composition of the protein coronas for a set of four silver nanoparticles, including citrate-stabilized and PVP-stabilized colloidal silver (~20 or ~110 nm diameter), were accomplished. The silver nanoparticles were incubated in DMEM supplemented with 10 % FBS, then washed several times, and the protein corona was solubilized and analyzed by label-free LC–MS/MS. The silver nanoparticles were found to be associated with a common subset of 11 proteins, including albumin, apolipoproteins, keratins, and other serum proteins. In fact, for the 110 nm citrate- and PVP-stabilized silver nanoparticles, the results showed binding to 79 and 85 proteins, respectively, and for the 20 nm citrate- and PVP-stabilized nanoparticles, the results showed binding of 45 and 48 proteins, respectively. The authors suggest that this is an indication that surface curvature effects are ruling the protein corona formation. Regarding the specificity of the silver nanoparticles studied, 19 proteins bound only the 20 nm silver nanoparticles (PVP and citrate), whereas 60 bound only the 110 nm silver nanoparticles (PVP and citrate). The authors indicate that these different protein profiles may also give a protein corona signature that is based on the size and/or surface curvature of the silver nanoparticles. However, it is important to point out that the total surface area available related to each of the nanoparticles studied (~20 and ~110 nm diameter) are completely different, which might affect the amount and composition of proteins binding to the nanoparticles. The difference in the total surface area available to bind proteins results from normalizing by weight the amount of nanoparticles used in the corona studies, in which the authors incubated 1 mg of each nanoparticle with the media. This highlights the need to start considering the total surface area as a parameter to be controlled in this type of studies.
Human blood plasma
Silver nanoparticles may supply antimicrobial efficacy when used as coatings on several biomedical devices. Therefore, it is very important to understand the interactions of silver nanoparticles with blood components (e.g., RBCs, WBCs, plasma proteins, etc.) [23, 75]. In human plasma, a typical nanoparticle protein corona consists of proteins such as HSA, immunoglobulins, fibrinogen, apolipoproteins, transferrin, complement proteins, and hemoglobin. The adsorption pattern of blood proteins to external inorganic surfaces is a functional event in which the most abundant proteins (e.g., HSA and fibrinogen) may initially be absorbed by the surface and then later replaced by other proteins that have a greater binding affinity for the surface (i.e., Vroman theory) . However, there is no universal theory that can be applied to all types of nanoparticles when exposed to human plasma . Human plasma protein corona formation on metallic nanoparticles (i.e., gold and iron) has been reported [78, 79]. However, we have not found reports in the literature for silver nanoparticles (to the best of our knowledge). Recently, using surface-enhanced Raman spectroscopy (SERS), interactions of silver nanoparticles with normal and cervical cancer human plasma collected from patients were reported . In this specific case that action of proteins and silver nanoparticles were used as markers for differentiation of normal and cancer human plasma. The prominent SERS peak is attributed to the amide I band of the human serum albumin (HSA) and in cancer this band was found to be higher than normal plasma, indicating that the elevated relative amount of proteins in the α-helix conformation was due to the cancer development. In other words, the selective proteins in cancer exert a different interaction with silver nanoparticles than normal plasma. These findings point towards the importance and role of the medium in the protein-nanoparticle interactions. Future studies that focus on a complete and accurate characterization of the corona and subsequently in the comparison of its composition in different disease conditions might give valuable information about the key proteins involved in the development and progress of certain illnesses.
Human serum albumin (HSA)
A study by Gebauer et al.  showed that the protein corona formed by human serum albumin (HSA) on citrate-functionalized silver nanoparticles stabilized them against agglomeration. One important aspect of this research was that agglomeration kinetics can be employed to prescribe apparent affinities to describe the protein adsorption/desorption equilibrium. Furthermore, circular dichroism spectroscopy was used as a complementary technique to measure affinities for the same process. The apparent KD values obtained using both approaches were correlated with other published values. The protein coronas found around silver nanoparticles in these experiments consisted of a monolayer of protein on the nanoparticle surfaces, corroborating previous results of HSA adsorption to polymer-coated nanoparticles .
Chen et al.  studied the interactions between citrate-silver nanoparticles and HSA using several methods, including UV–Vis, TEM, and CD measurements, and found that silver nanoparticle-HSA binding was mediated by the physical forces of hydrogen bonding, electrostatic interaction, and hydrophobic interaction. In this study, the percent of α-helices was reduced, whereas that of β-sheets increased in the secondary HSA structures after interaction with silver nanoparticles. The authors suggested that this was a result of hydrogen bond breakage between proximal α-helices and configuration of new, less ordered hydrogen bonds between the α-helices and the citrate coating of the silver nanoparticles. CD measurements indicated that the presence of lipid vesicles (i.e., the membrane model) relaxed the conformational changes of the proteins induced by the nanoparticles, most likely due to the electrostatic repulsion between them. Generalized polarization (GP; fluorescence ratio) measurements demonstrated that nanoparticles and protein coronas interact with lipid vesicles to enhance their fluidity. In contrast, free proteins did not exert this effect on vesicle conformation. Utilizing these results, the authors suggested that in the formation of nanoparticle protein coronas, the physical interactions between the nanoparticle core and cell membranes probably did not occur easily. The implications of these results together with the biological and biochemical mechanisms of endocytosis, lipid peroxidation, and enzymatic activity, could be an important issue in nanomedicine and nanotoxicology applications .
After a 2-h pre-incubation with proteins (HSA/transferrin), citrate-silver nanoparticles (20 and 110 nm) were studied as they acted on human epidermal keratinocyte (HEK) cells, and the cellular uptake showed that for 20 and 110 nm citrate silver nanoparticles, protein incubation significantly modulated silver nanoparticle uptake. Silver incubation with albumin and IgG, and in a minor extension with transferrin, reduced the extent of cellular uptake . Moreover, IgG exposure dramatically reduced the 110 nm citrate silver uptake. Similar profiles were also found with silver nanoparticles in the membrane fraction with protein incubation in general, significantly altering the association of the particle to the membrane. Silver nanoparticles, independent of size and protein exposure, were found inside the cytoplasmic vacuoles of the HEKs.
Figure 8 shows a transmission electron micrograph that has captured several 120 nm silica-coated silver nanoparticles in the process of phagocytosis by a HEK cell.
The 20 nm citrate silver nanoparticles bound to albumin were highly dispersed and appeared to break down or disintegrate within the vacuoles, whereas nanoparticles bound to IgG, transferrin, and the native control showed very low agglomeration. However, for 20 nm citrate coated silver nanoparticles, protein incubation reduced cellular concentrations, and for the 110 nm citrate silver nanoparticles, incubation with IgG significantly reduced the uptake of silver nanoparticles. The authors stated that this pattern of protein modulation of silver nanoparticle uptake was not as important compared with that of different proteins that clearly modify silver nanoparticle uptake into HEK. They also discussed the cytoplasmic data that showed that nanoparticles certainly entered the cellular domain, which brought up questions as to how in vitro assays using native nanoparticles could be correlated to what would be expected to occur in vivo .
In the case of HAS, the incubation significantly modulated silver nanoparticle uptake independently of the nanoparticles sizes. The incubation with albumin and IgG, and in a minor extension with transferrin, reduced the extent of cellular uptake.
Tubulin (cytoskeletal protein)
In a study with actin and tubulin (cytoskeletal proteins) interacting with citrate-silver nanoparticles, both gave high standard deviations for the zeta potentials. The silver nanoparticles had a diameter of 35.7 nm and a zeta potential of −42.5 mV and actin had a diameter of 2.0 nm and a zeta potential of −28.0 mV, while actin-silver nanoparticles had a diameter of 39.4 and a zeta potential of −36.6 mV. It was suggested that this was due to self-aggregation and less extensive polymerization. The actin-silver nanoparticles exhibited a smaller deviation in zeta potential than the tubulin-silver nanoparticles, indicating that the protein corona from actin-silver nanoparticles was more homogeneous than the tubulin-silver nanoparticles. As discussed previously, the secondary structures of actin and tubulin were altered after interaction with silver nanoparticles. The α-helices of actin showed a 24 % decrease whereas the β-sheets showed a 36 % increase upon binding to the silver nanoparticles, and no random coils were observed. For tubulin, a 17 % decrease and 5 % increase in α-helices and β-sheets, respectively, was demonstrated. In the latter protein, 11 % random coils were found after binding with silver nanoparticles. The conformational changes were more significant for actin than tubulin, corroborating the UV–Vis absorbance measurements and the hyperspectral imaging. Other important aspects of this report included silver ion release in these types of interactions. In the absence of cytoskeletal proteins, silver nanoparticles rapidly released silver ions for the first 4 h, but the rate of release subsequently leveled off for a period of 72 h (5 % dissolution). In the presence of actin and tubulin, however, the release of silver ions progressed at a slower pace, where only 1 % dissolution was attained during the first few hours (Fig. 9).
These data imply that coating silver nanoparticles with cytoskeletal proteins physically prevented release of the silver ions, and the conformation and physicochemical properties of silver nanoparticles were improved by hardened cytoskeletal proteins .
Ubiquitin (a structurally conserved protein that regulates numerous in eukaryotic cell processes)
Ding et al.  used a combination of molecular dynamics simulations and complementary experiments to characterize the ubiquitin corona on citrate silver nanoparticles of around 13 nm (Fig. 10). To measure the impact of silver nanoparticles on the ubiquitin conformation, the Q-value was studied for all protein residues, which is the fraction of native contacts for silver nanoparticles when bound to ubiquitin or unbound. The Q-values were close to 1, indicating that both components maintained native-like structures. The loop regions between the secondary structures had relatively low Q-values. A region near the C-terminus of the helix and another close to residue 46 in a loop were strongly destabilized upon binding with silver nanoparticles. These data were consistent with results from circular dichroism, where the helical content was reduced by 27.8 % by the silver nanoparticle-bound ubiquitin compared to free ubiquitin. These measurements also showed a slight increase in the β-sheet content. The authors hypothesized that as a function of protein concentration on the silver nanoparticle surfaces, the increase in β-sheet content could be due to the formation of inter-protein hydrogen bonds through partially unfolded protein regions.
Hyaluronan is a major component of cell-surface glycoproteins and the extracellular matrix, surface adsorbed hyaluronan-binding proteins may act as “bridges” that mediate the interaction of nanoparticles with the cell surface. Recently Walkey et al.  noted that using quantitative models (a bioinformatics-inspired approach) to predict the biological interactions of nanoparticles that they included for the characterization of the blood protein coronas is the most comprehensive quantitative analysis published to date. The model implicated a collection of hyaluronan-binding proteins as mediators of silver nanoparticle-cell interactions. They also indicated the probability of using this database to develop exact relationships that can predict the biological responses to nanoparticles and potentially help in uncovering the basic nano-bio interaction mechanisms.
Yeast extracted proteins
Eigenheer et al.  reported an approach where mass spectrometry proteomics was implemented to determine protein corona populations (from yeast extract) and to measure protein enrichment on the surfaces of different silver nanoparticle [negative citrate-coated particles (10 and 100 nm) and positive branched polyethyleneimine coated particles (100 nm)] under biologically and environmentally important reaction conditions. BY4 yeast was cultured and the cells treated to obtain the protein content. After incubation of 0.25 mg mL−1 nanoparticles and 0.21 mg mL−1 soluble yeast protein extract for 16 h, the nanoparticles and adsorbed proteins were precipitated, centrifuged and washed several times to remove non-associated and loosely associated proteins from the nanoparticles. Nanoparticle adsorbed proteins were directly digested off the nanoparticles (e.g., trypsin) for identification of well adsorbed and low abundance corona proteins. More than 500 proteins were identified in the sample studied, including nanoparticles with associated and unassociated proteins. To understand the role of silver nanoparticle properties in protein corona formation, the protein–nanoparticle interaction was carried out with low salt and buffer concentrations. The protein coronas of citrate-silver nanoparticles (10 nm, negative) were compared to polyethyleneimine-silver nanoparticles (10 nm, positive) and citrate-silver nanoparticles (100 nm, negative) to investigate the roles of surface charge and size, respectively. The data from the protein corona concentration experiments clearly indicated that the charge on the surface of the silver nanoparticles played a greater role in corona formation than did their size. The authors presented a Venn diagram to compare the different protein corona populations and found that 10 and 100 nm (negative) citrate-silver nanoparticles were the most similar, with approximately 83 % of proteins (376 proteins) shared across their protein corona distributions. Meanwhile, the differences provided insight into the importance of nanoparticle properties. Notably, approximately 50 % of the proteins (247 proteins) were found within the coronas of all nanoparticles studied, which demonstrated that these proteins would be found on the nanoparticles independent of their surface coating or size and are therefore an important group of proteins that must be studied in further detail. The authors also suggested that the surface charge, an apparent biophysical property of the proteins studied, probably regulates binding to silver nanoparticles, as shown clearly in Fig. 11. Here, there was an increase in the abundance of negatively charged proteins that bind to (+) silver nanoparticles compared to the 10 and 100 nm (−) silver nanoparticles. In other words, there was a two-fold decrease in the anionic proteins bound to 10 nm (34 %) and 100 nm (−) silver nanoparticles (20 %), compared to (+) silver nanoparticles (71 %). These data demonstrated that electrostatics is a determinant factor in the modulation of protein affinity for silver nanoparticles. Finally, the authors stated that, at the most basic level, all of this information reaffirms the importance of ample nanoparticle characterization and the reaction conditions when analyzing the protein coronas of nanoparticles.
Biological activities related to the protein corona
The antibacterial activities of borate-silver, citrate-silver and PVP-silver nanoparticles were studied. Borate-silver nanoparticles were inactive against Salmonella when tested in Luria–Bertani (LB) broth, but were efficient against Salmonella in PBS buffer. When antibacterial activity was tested in PBS (no blood, serum or plasma present), no activity differences were found for the different types of silver nanoparticles. However, blood, serum or plasma completely inhibited the activity of borate-silver nanoparticles but not citrate-silver or PVP-silver nanoparticles. The activity of the PVP-silver nanoparticles was stronger than that of the citrate-silver nanoparticles. Nanoparticle activity against S. typhimurium was studied in the presence of mouse blood components, whereas for S. typhi, the activity was analyzed in the presence of human blood components. Serum albumin is the major component of blood; 3 % BSA was used to measure the antibacterial effects of the silver nanoparticles under study. BSA addition totally abolished the antibacterial activity of the borate-silver nanoparticles but not that of the citrate- or PVP-silver nanoparticles .
Citrate- and PVP-silver nanoparticles presented antibacterial properties in LB broth. The authors suggested that this might be due to the prevention of interaction of silver nanoparticles via the LB components or the inhibition of agglomeration of these particles.
A murine salmonellosis model was used by the same authors to understand the effect of the capping agent on the silver nanoparticles. BALB/c mice were infected with S. typhimurium (orally/i.v.), and the bacterial burdens in the mesenteric lymph nodes, spleen, and liver were studied. No effect of silver nanoparticles was observed when borate-silver nanoparticles (described as uncapped-silver nanoparticles) were administered to treat the Salmonella infection, whereas citrate- and PVP-silver nanoparticles reduced the bacterial burden in different organs; PVP-silver nanoparticles showed an efficient antibacterial effect. Finally, when the borate-silver nanoparticles were used, all mice died after the same period as in the controls, whereas oral and i.v. administration of citrate- or PVP-silver nanoparticles delayed the death of the mice. However, when the silver nanoparticles were all administered intravenously, the PVP- and citrate-silver nanoparticles protected 60 and 40 % of the mice from death, respectively. This difference between oral and i.v. administration was attributed to the fact that silver nanoparticles from oral administration were excreted through the feces. The authors noted that this study was the first to show the role of the capping agent in antibacterial activity under physiological conditions in an animal model and also how the efficacy of silver nanoparticles varies between PBS and biological fluids . As previously discussed, not only in in vitro studies but also in vivo antibacterial activity of silver nanoparticles depends on the capping agents.
Citrate-silver nanoparticles were found by Shannahan et al.  to readily associate and form protein coronas with human serum albumin (HSA), bovine serum albumin (BSA), and high density lipoprotein (HDL). The accumulation of all protein coronas increased the hydrodynamic sizes of the silver nanoparticles. The addition of HSA and BSA reduced the dissolution of silver nanoparticles (silver ion formation), whereas, for HDL, dissolution increased compared with silver nanoparticles in water. The authors suggested that this occurred because of a reduction in the zeta potential of the HDL-silver nanoparticles compared with other samples. Moreover, HDL probably offset citrate groups and produced a destabilization of the silver nanoparticles, generating an increase in total dissolution. Circular dichroism measurements showed that protein association with silver nanoparticles decreased the number of α-helices in all protein coronas, but for HDL-silver nanoparticles, the number of α-helices increased. For HSA and BSA, this increase probably arose from entropy-driven unfolding of the protein and the formation of hydrogen bonding between the proteins and the silver nanoparticles. However, for HDL, this probably did not occur because this material has a high lipid content and a high degree of structural complexity. Additionally, the number of β-sheets increased in all proteins, and protein turns as well as the quantity of unordered proteins were also discussed. An important topic investigated by this research was the role of the protein corona in the toxicity induced by silver nanoparticles in two cell types that are common targets of nanoparticle exposure, rat lung epithelial (RLE) and rat aortic endothelial (RAEC) cells. As observed by hyperspectral analysis, the protein coronas on the silver nanoparticles were lost after internalization and these nanoparticles activated cells by inducing IL-6 mRNA expression. Pretreatment with an SR-BI inhibitor (inhibitor of the HDL receptor) diminished the internalization of silver nanoparticles both with and without a protein corona, and it reduced cytotoxicity and IL-6 mRNA expression. Therefore, this study characterized the formation of a protein corona on silver nanoparticles and showed its influence on cell activation and cytotoxicity through cell surface receptors.
In 2014, citrate-silver nanoparticles functionalized with three different thioglycosides (glucose-, galactose-, and mannose-silver nanoparticles) and thioglycol-silver nanoparticles were synthesized by Kennedy et al. . The cytotoxicity of these functionalized silver nanoparticles were tested against a neuron-like cell line (Neuro-2A) and a hepatocyte cell line (HepG2). The coating was clearly important for their toxicity. Glycol-, glucose- and citrate-functionalized silver nanoparticles exhibited a similarly high toxicity. However, galactose- and mannose-functionalized nanoparticles were significantly less toxic towards both cell lines. The formation of protein carbonyls was analyzed as an indirect mark for the oxidative stress induced by nanoparticles because proteins can become carboxylated either as a direct or an indirect consequence of reactive oxygen species formation (Fig. 12).
The authors found a strong correlation between carbonyl formation and EC50 values, suggesting that toxicity is predominantly caused by the oxidative stress related to ROS formation. However, it is also possible that toxicity can arise from different cellular uptake rates. An ICP-MS and confocal microscopy experiment showed that for both cell lines, the less toxic galactose-functionalized nanoparticles were taken up more efficiently compared to mannose- or glucose-functionalized particles, which was probably due to a galactose-specific receptor on the surface of the cells. In other words, higher cell internalization does not necessary indicate higher toxicity. The glucose-silver nanoparticles caused the highest toxicity and protein carboxylation but not the highest cellular uptake, when compared with the other functionalized nanoparticles. A confocal microscopy image of the Neuro-2A cells showed that the galactose-silver nanoparticles were mainly inside the cytoplasm (e.g., inside vesicular structures) but not in the nucleus. For the mannose- and glucose-silver nanoparticles, their clusters appeared more evenly dispersed throughout the cell, and the intracellular clusters were smaller than those of particles with other functional groups. Another aspect that these authors discussed was the importance of surface charge for cellular internalization. In these experiments, there was a correlation between the uptake and surface charge for mannose, glucose and ethylene glycol silver nanoparticles, which are more negatively charged and taken up less efficiently. These data were consistent with their expectations because the cell lines used were also negatively charged owing to their various carbohydrate moieties. However, the authors also suggested that in addition to special receptors on the cell surface, there are also protein coronas on their surfaces from interaction with the culture medium. Zeta potential measurements after incubation showed that all particles exhibited similar overall negative charges, confirming the formation of protein coronas. Presumably, the protein corona composition on the surface of the functionalized particles in this study was expected to be different depending on particle coating, and the authors clearly found a correlation between particle coating, oxidative stress and toxicity . It is clear from this study that the formation of a protein corona on silver nanoparticles influenced cell activation and cytotoxicity through cell surface receptors.
Based on all data related to silver nanoparticles and their protein coronas and depending on factors such as size, concentration and surface functionalization, unexpected interactions with different blood components or any biological fluids could interfere with biomedical applications, such as antibacterial, antifungal or anticancer treatment in vivo. The scientific community is still in the beginning of the exploration of this new subject and interestingly, all studies conducted to this end have focused on human plasma as the test system for protein corona studies. Though of extremely importance to mimic and study biological interactions with these nanomaterials, the use of this model is still deficient for studies with silver nanoparticles. We could see from this review that circular dichroism was extensively used to confirm the interactions between single proteins and silver nanoparticles, confirming a dynamic type of interaction that could lead to protein unfolding. Extending these findings to a biological milieu, the changes in the secondary structure of proteins as a result from protein–nanoparticle interaction could lead to different cell responses and activation processes, which is still in need of further investigation. Understanding the interaction of these protein coronas with cells could lead to understanding of their immunotoxicity or its reduction by silver nanoparticles capped with protein corona. In some cases, silver nanoparticle cytotoxicity was mitigated, depending on protein corona composition. Recently Lee et al.  stated that there is limited understanding of the connection between the physicochemical properties of any nanoparticle and their corresponding effects on physiological systems. We agree with this statement in the context of silver nanoparticles. However, depending of the application route, many advances for in vivo applications have been made by functionalization. We will probably see in vivo applications of silver nanoparticles in the near future. However, a major challenge will be to compare data across interlaboratory studies, which is found to be difficult so far as most of them do not follow same conditions. This reveals an urgent need to better control the parameters of the experiments as well as to standardize some of conditions, e.g. particle concentration, total surface area available and biological fluids conditions, thus making possible to build a strong and solid database.
Ashkarran AA, Ghavami M, Aghaverdi H, Stroeve P, Mahmoudi M (2012) Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles. Chem Res Toxicol 25:1231–1242
Lem KW, Choudhury A, Lakhani AA, Kuyate P, Haw JR, Lee DS, Iqbal Z, Brumlik CJ (2012) Use of nanosilver in consumer products. Rec Pat Nanotec 6:60–72
Faria AF, Martinez DST, Meira SMM, Moraes ACM, Brandelli A, Souza Filho AG, Alves OL (2014) Anti-adhesion and antibacterial activity of silver nanoparticles supported on graphene oxide sheets. Colloid Surf B 113:115–124
Rai M, Kon K, Ingle A, Durán N, Galdiero S, Galdiero M (2014) Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol 98:1951–1961
Rai M, Ingle A, Gaikwad S, Gupta I, Yadav A, Gade A, Durán N (2015) Fungi: myconanofactory, mycoremediation and medicine. In: Deshmukh SK, Misra JK, Tiwari JP, Papp T (eds) Fungi and their applications under the series of progress in mycological research. CRC Press, USA (in press)
Tran QH, Nguyen VQ, Le AT (2013) Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci Nanosci Nanotechnol 4:033001
Han JW, Gurunathan S, Jeong J-K, Choi Y-J, Kwon D-N, Park J-K, Kim J-H (2014) Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line. Nanosc Res Let 9:459
Durán N, Marcato PD, De Conti R, Alves OL, Costa FTM, Brocchi M (2010) Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc 21:949–959
Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M (2011) Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7(1):347–354
De Lima R, Seabra AB, Durán N (2012) Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol 32:867–879
Lima R, Feitosa LO, Ballottin D, Marcato PD, Tasic L, Durán N (2013) Cytotoxicity and genotoxicity of biogenic silver nanoparticles. J Phys Conf Ser 429:012020
Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608–13619
Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briedé JJ, van Loveren H, de Jong WH (2011) The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomat 32:9810–9817
AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–290
AshaRani PV, Hande MP, Valiyaveettil S (2009) Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 10:65
Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH (2009) A case of generalized argyria after ingestion of colloidal silver solution. Am J Ind Med 52:246–250
Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY (2009) Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 23:1076–1084
Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–983
Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ (2006) The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 92:456–463
Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH (2007) Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol 19:59–65
Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC (2005) In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88:412–419
Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager JJ, Hussain SM, Hofmann MC (2010) Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. Toxicol Sci 116:577–589
Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA (2011) Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 123:133–143
Cronholm P, Karlsson HL, Hedberg J, Lowe TA, Winnberg L, Elihn K, Wallinder IO, Moller L (2013) Intracellular uptake and toxicity of Ag and CuO nanoparticles: a comparison between nanoparticles and their corresponding metal ions. Small 9:970–982
Grosse S, Evje L, Syversen T (2013) Silver nanoparticle-induced cytotoxicity in rat brain endothelial cell culture. Toxicol In Vitro 27:305–313
Ciftci H, Turk M, Tamer U, Karahan S, Menemen Y (2013) Silver nanoparticles: cytotoxic, apoptotic, and necrotic effects on MCF-7 cells. Turk J Biol 37:573–581
Faedmaleki F, Shirazi FH, Salarian A-A, Ashtiani HA, Rastegar H (2014) Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res 13:235–242
Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL (2014) Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Particle Fibre Toxicol 11:11
Sengstock C, Diendorf J, Epple M, Schildhauer TA, Köller M (2014) Effect of silver nanoparticles on human mesenchymal stem cell differentiation. Beilstein J Nanotechnol 5:2058–2069
Massarsky A, Abraham R, Nguyen KC, Rippstein P, Tayabali AF, Trudeau VL, Moon TW (2014) Nanosilver cytotoxicity in rainbow trout (Oncorhynchus mykiss) erythrocytes and hepatocytes. Comp Biochem Phys C 159:10–21
Tiwari DK, Jin T, Behari J (2011) Dose-dependent in vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods 21:13–24
Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF (2009) Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187:15–21
Kawata K, Osawa M, Okabe S (2009) In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Envir Sci Tech 43:6046–6051
Behra R, Sigg L, Clift MJD, Herzog F, Minghetti M, Johnston B, Petri-Fink A, Rothen-Rutishauser B (2013) Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface 10:20130396
Wang B, Feng W, Zhao Y, Chai Z (2013) Metallomics insights for in vivo studies of metal based nanomaterials. Metallomics 5:793
Comfort KK, Maurer EI, Braydich-Stolle LK, Hussain SM (2011) Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano 5:10000–10008
Stevanovic M, Kovacevic B, Petkovic J, Filipic M, Uskokovic D (2011) Effect of poly-alpha, gamma, l-glutamic acid as a capping agent on morphology and oxidative stress-dependent toxicity of silver nanoparticles. Int J Nanomed 6:2837–2847
Stevanovic M, Uskokovic V, Filipovic M, Skapin SD, Uskokovic D (2013) Composite PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive, antioxidative, and antimicrobial activities. ACS Appl Mater Interfaces 5:9034–9042
Filipović N, Stevanović M, Radulović A, Pavlović V, Uskoković D (2013) Facile synthesis of poly(ε-caprolactone) micro and nanospheres using different types of polyelectrolytes as stabilizers under ambient and elevated temperature. Compos Part B 45:1471–1479
Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D, Kulthong K, Chanvorachote P, Maniratanachote R (2013) Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol In Vitro 27:330–338
Shannahan JH, Podila R, Aldossari AA, Emerson H, Powell BA, Ke PC, Rao AM, Brown JM (2015) Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci 143:136–146
Miclăuş T, Bochenkov VE, Ogaki R, Howard KA, Sutherland DS (2014) Spatial mapping and quantification of soft and hard protein coronas at silver nanocubes. Nano Lett 14(4):2086–2093
Lee YK, Choi E-J, Webster TJ, Kim S-H, Khang D (2015) Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Inter J Nanomed 10:97–113
Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 104:8691–8696
Cukalevski R, Lundqvist M, Oslakovic C, Dahlback B, Linse S, Cedervall T (2011) Structural changes in apolipoproteins bound to nanoparticles. Langmuir 27:14360–14369
Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA (2010) What the cell “sees” in bionanoscience. J Am Chem Soc 132:5761–5768
Monopoli MP, Åberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–786
Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050–2055
Klein J (2007) Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci USA 104:2029–2030
Rocker C, Potzl M, Zhang F, Parak WJ, Nienhaus GU (2009) A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4:577–580
Treuel L, Malissek M, Gebauer JS, Zellner R (2010) The influence of surface composition of nanoparticles on their interactions with serum albumin. Chem Phys Chem 11:3093–3099
Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155–7167
Monopoli MP, Baldelli Bombelli F, Dawson KA (2011) Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol 6:11–12
Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011) Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–2534
Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF (2009) Differential plasma protein binding to metal oxide nanoparticles. Nanotech 20:455101–455109
Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–14270
Lesniak A, Fenaroli F, Monopoli MP, Abberg C, Dawson KA, Salvati A (2012) Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845–5857
Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011) Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 111:5610–5637
Delpino P, Pelaz B, Zhang Q, Maffre P, Nienhaus GU, Parak WJ (2014) Protein corona formation around nanoparticles—from the past to the future. Mater Horiz 1:301–313
Durán N, Marcato PD, Durán M, Yadav A, Gade A, Rai M (2011) Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants. Appl Microbiol Biotechnol 90:1609–1624
Durán N, Marcato PD (2012) Biotechnological routes to metallic nanoparticles production: mechanistic aspects, antimicrobial activity, toxicity and industrial applications. In: Rai M, Cioffi N (eds) Nano-antimicrobials: progress and prospects. Springer, Germany, pp 337–374 (Part 3)
Balachandran YL, Girija S, Selvakumar R, Tongpim S, Gutleb AC, Suriyanarayanan S (2013) Differently environment stable bio-silver nanoparticles: study on their optical enhancing and antibacterial properties. PLoS One 8:e77043
Eckhardt S, Brunetto PS, Gagnon J, Priebe M, Giese B, Fromm KM (2013) Nanobio silver: it’s interactions with peptides and bacteria, and it’s uses in medicine. Chem Rev 113:4708–4754
Edmundson MC, Capeness M, Horsfall L (2014) Exploring the potential of metallic nanoparticles within synthetic biology. New Biotechn 31:572–578
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) (2014) Nanosilver: safety, health and environmental effects and role in antimicrobial resistance. http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1494. Accessed June 2014
Treuel L, Malissek M, Grass S, Diendorf J, Mahl D, Meyer-Zaika W, Epple M (2012) Quantifying the influence of polymer coatings on the serum albumin corona formation around silver and gold nanoparticles. J Nanopart Res 14:1–12
Ravindran A, Singh A, Raichur AM, Chandrasekaran N, Mukherjee A (2010) Studies on interaction of colloidal Ag nanoparticles with bovine serum albumin (BSA). Colloids Surf B Biointerfaces 76:32–37
Mariam J, Dongre P, Kothari D (2011) Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. J Fluoresc 21:2193–2199
Podila R, Chen R, Ke PC, Brown JM, Rao AM (2012) Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett 101:263701
Shannahan JH, Lai X, Ke PC, Podila R, Brown JM, Witzmann FA (2013) Silver nanoparticle protein corona composition in cell culture media. PLoS One 8:e74001
Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz LJM, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Koller M, Epple M (2010) The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 20:512–518
Kittler S, Greulich C, Diendorf J, Köller M, Epple M (2010) Toxicity of silver nanoparticles increases during storage due to slow dissolution under release of silver ions. Chem Mater 22:4548–4554
Liu R, Sun F, Zhang L, Zong W, Zhao X, Wang L, Wu R, Hao X (2009) Evaluation on the toxicity of nanoAg to bovine serum albumin. Sci Total Environ 407:4184–4188
Casals E, Pfaler T, Duschl A, Oostingh GJ, Puntes VF (2011) Hardening of the nanoparticle–protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. Small 7:3479–3486
Laloy J, Minet V, Alpan L, Mullier F, Beken S, Toussaint O, Lucas S, Dogné J-M (2014) Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine 1:1–9
Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotech 11:1–12
Pearson RM, Juettner VV, Hong S (2014) Biomolecular corona on nanoparticles: a survey of recent literature and it implications in targeted drug delivery. Front Chem 2:1–7
Beneti F, Fedel M, Minati L, Speranza G, Migliaresi C (2013) Gold nanoparticles: role of size and surface chemistry on blood protein adsorption. J Nanopart Res 15(1694):1–9
Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H (2014) Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Reports 4:1–9
Feng S, Lin D, Lin J, Li B, Huang Z, Chen G, Zhang W, Wang L, Pan J, Chen R, Zeng H (2013) Blood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancer. Analyst 138:3967–3974
Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, Peukert W, Treuel L (2012) Impact of the nanoparticle–protein corona on colloidal stability and protein structure. Langmuir 28:9673–9679
Chen R, Choudhary P, Schurr RN, Bhattacharya P, Brown JM, Ke PC (2012) Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. Appl Phys Lett 100:013703
Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE (2013) Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett 220:286–293
Wen Y, Geitner NK, Chen R, Ding F, Chen P, Andorfer RE, Govindan PN, Ke PC (2013) Binding of cytoskeletal proteins with silver nanoparticles. RSC Adv 3:22002–22007
Ding F, Radic S, Choudhary P, Chen R, Brown JM, Pu Chun Ke PC (2013) Direct observation of silver nanoparticle-ubiquitin corona formation. Nanosc. 5:9162–9169
Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DWH, Cohen Y, Emili A, Chan WCW (2014) Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8:2439–2455
Eigenheer R, Castellanos ER, Nakamoto MY, Gerner KT, Lampeb AM, Wheeler KE (2014) Silver nanoparticle protein corona composition compared across engineered particle properties and environmentally relevant reaction conditions. Environ Sci Nano 1:238–247
Gnanadhas DP, Thomas MB, Thomas R, Raichur AM, Chakravortty D (2013) Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother 57:4945–4955
Kennedy DC, Orts-Gil G, Lai C-H, Moller L, Haase A, Luch A, Seeberger PH (2014) Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake. J Nanobiotechnol 12:59
ND collected research data. ND, CPS, MD and DSTM analyzed the data and wrote this review. All authors read and approved the final manuscript.
Support from FAPESP, CNPq, INOMAT (MCTI/CNPq), NanoBioss (MCTI) and Brazilian Network on Nanotoxicology (MCTI/CNPq) are acknowledged.
Compliance with ethical guidelines
Competing interests The authors declare that they have no competing interests.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Durán, N., Silveira, C.P., Durán, M. et al. Silver nanoparticle protein corona and toxicity: a mini-review. J Nanobiotechnol 13, 55 (2015). https://doi.org/10.1186/s12951-015-0114-4
- Silver nanoparticles
- Protein corona